Author

M. Haloul

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Approach:biophysical modeling· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Assay:imaging· 1

Frequent Co-Authors

A. K. Kaushik· 1 shared A. M. Gajda· 1 shared B. Faubert· 1 shared B. Ko· 1 shared C. Yang· 1 shared E. E. Er· 1 shared E. L. Wiley· 1 shared F. Cai· 1 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. K. Kaushik

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Multiplex Imaging Reveals Novel Subcellular, Microenvironmental, and Racial Patterns of MRTFA/B Activation in Invasive Breast Cancers and Metastases

S. M. Wilk, K. Lee, A. M. Gajda, M. Haloul, V. Macias, E. L. Wiley, Z. Chen, X. Liu, X. Wang, M. Sverdlov, K. F. Hoskins, E. E. Er

The paper uses multiplex imaging and bioinformatics to show distinct MRTFA/B activation patterns in breast cancer subtypes and racial disparities in MRTFA expression.

bioRxiv · Jan 3, 2024 · PreprintCancer Biology

The hexosamine biosynthesis pathway is a targetable liability in lung cancers with concurrent KRAS and LKB1 mutations.

J. Kim, F. Cai, B. Ko, C. Yang, H. M. Lee, N. Muhammad, K. Li, M. Haloul, W. Gu, B. Faubert, A. K. Kaushik, L. Cai, S. Kasiri, U. Marriam, K. Nham, , R. J. DeBerardinis

The paper identifies the hexosamine biosynthesis pathway as a metabolic vulnerability in KRAS/LKB1 mutant lung cancers and shows GFPT2 inhibition reduces tumor growth.

bioRxiv · Apr 13, 2020 · PreprintCancer Biology